[ Tips ] 一分鐘使用導覽
商品編號： 9-721-373 出版日期： 2021/01/26 作者姓名： Collis, David J.;Sato, Nobuo;Kanno, Akiko 商品類別： Other 商品規格： 22p 再版日期： 地域： Japan 產業： Pharmaceutical industry;Biotechnology industry 個案年度： -
商品敘述：
This case follows Christophe Weber, President and CEO of Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, as Takeda considers acquiring Shire Plc, a biotech company based in Ireland. The acquisition would turn Takeda into a top ten global pharmaceutical company; however, other pharma companies were showing initial interest in acquiring Shire, and the acquisition would require a large amount of funding. Other concerns about the bid were nonfinancial. Over the last two decades, Takeda had aggressively pursued globalization and was now a global company with two thirds of revenue raised outside Japan and a diverse management team. What was the implication of acquiring Shire? Was now the right time to take such a big step? Was the acquisition in line with the company''s goals? How would the combined company be managed? Would the acquisition put an end to Takeda as a Japanese company?
涵蓋領域：
Business goals;Business management;Global strategy;Globalization;Mergers and acquisitions;Talent management
相關資料：
哪些人也有訂購？